OncBioMune Pharmaceuticals Establishes Another Revenue Stream; Schedules First Patient with AAT Deficiency for Treatment in Mexico
June 28, 2017 13:02 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - June 28, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development...
Enrollment to Begin in OncBioMune's Trial of ProscaVax for Prostate Cancer in Mexico
June 27, 2017 10:42 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - June 27, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of...
OncBioMune Receives Patent Protecting Novel Cancer Vaccine in Mexico
June 21, 2017 09:37 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - June 21, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of...
OncBioMune Awarded Patent for ProscaVax in Japan
June 20, 2017 14:11 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - June 20, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of...
OncBioMune Acquires Norepinefrine for Low Blood Pressure and Heart Failure in Mexico from Teva Pharmaceuticals Mexico
June 19, 2017 11:55 ET
|
OncBioMune Pharmaceuticals, Inc.
MEXICO CITY, MEXICO--(Marketwired - June 19, 2017) - OncBioMune México, S.A. De C.V., (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the...
OncBioMune, AqVida add additional drugs to distribution agreement (Paclitaxel and Oxaliplatin)
June 15, 2017 12:55 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - June 15, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development...
OncBioMune Protects ProscaVax Cancer Treatment Technology in Hong Kong
June 07, 2017 09:55 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - June 07, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development...
OncBioMune's Andfrt(R) Shown in Clinical Trial to Improve Sperm Count and Mobility
June 06, 2017 09:40 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - June 06, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of...
Protocol Submitted to FDA for Phase 2 Clinical Trial of ProscaVax as Immunotherapy for Early-Stage Prostate Cancer
June 01, 2017 08:30 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - June 01, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development...
OncBioMune Reports Record Monthly Sales for Bekunis(R) in May
May 31, 2017 09:42 ET
|
OncBioMune Pharmaceuticals, Inc.
BATON ROUGE, LA--(Marketwired - May 31, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development...